AnGes MG licenses in cervical cancer vaccine Genorac BL from BioLeaders, South Korea

The human papillomavirus (HPV) vaccine was invented by BioLeaders and will be clinically developed in Japan by Tokyo Medical School

AnGes MG press release, April 3, 2013

AnGes MG licenses in cervical cancer vaccine Genorac BL from BioLeaders, South Korea
Scroll to top